CHRNB4
protein-codingcholinergic receptor nicotinic beta 4 subunit, the group of Cholinergic receptors nicotinic subunits
Gene summary
This gene is found within a conserved gene cluster and encodes one of the beta subunits of the nicotinic acetylcholine receptor (nAChRs) superfamily which form ligand-gated ion channels with a central pore that forms a cation channel. Neuronal nAChRs are pentameric structures that can be either homomeric or heteromeric, with heteromeric structures containing both alpha and beta subunits. Each subunit contains an extracellular amino terminus and four transmembrane domains. Nicotine is one of the agonists that binds to the receptor. Variants in this gene have been associated with nicotine dependence and lung cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~103.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008903
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CHRNB4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000750.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 3 | 6 | |||
| missense | 2 | 44 | 6 | 4 | 56 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 2 | 45 | 9 | 7 | 63 |
Highest pathogenic variant AF is 0.00003717509
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000741.1 | 6 | MANE Select | |
| Ensembl | ENSP00000261751.3 | 6 | MANE Select | |
| RefSeq | NP_001243496.1 | 5 | Standard | |
| Ensembl | ENSP00000416386.2 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuroactive ligand-receptor interaction - Homo sapiens (human)
- Cholinergic synapse - Homo sapiens (human)
- Nicotine Pathway (Chromaffin Cell), Pharmacodynamics
- Nicotine Activity on Chromaffin Cells
- Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways
Biological Process
- action potential
- ion transport
- smooth muscle contraction
- regulation of smooth muscle contraction
- signal transduction
Molecular Function
- extracellular ligand-gated ion channel activity
- protein binding
- ligand-gated ion channel activity
- acetylcholine receptor activity
- acetylcholine-gated cation-selective channel activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- acetylcholine-gated channel complex
- integral component of membrane
- cell junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000261751
- Coding exons
- 6
- Length
- 103636
- Individuals with no LoFs
- 125729
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 19
- Defined
- 125748
- p
- 0.0000756
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.20 | 257 | 317 | 0.811 | 0.0000200 | 3246 |
| Missense (PolyPhen) | 107 | 150.54 | 0.71078 | 1653 | ||
| Synonymous | -1.01 | 152 | 137 | 1.11 | 0.00000957 | 1029 |
| Loss of Function | 2.95 | 5 | 18.8 | 0.266 | 9.76e-7 | 190 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00014 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000097 | 0.000097 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.;
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- LoFtool
- 0.144
- RVIS EVS
- 0.73
- RVIS percentile EVS
- 86.3
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.154
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |